JPRN-UMIN000010248已完成未知
Effects of Insulin Degludec versus Insulin Glargine in basal-bolus treatment in type 2 diabetes assessed by continuous glucose monitoring system - JUN-SIBA study:Juntendo-Soluble Insulin Basal Analogue study
Juntendo University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2013年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with past medical history of hypersensitivity to Degludec. 2.Patients with serious liver,renal,pituitary and adrenal insufficiency. 3.Patients with diarrhea, vomiting and other gastrointestinal problems. 4.Patients with starvation state or unstable appetite. 5.Patients with serious diabetic complications including proliferative retinopathy. 6.Patients who are pregnant, hope to be pregnant, or are in lactation period. 7.Judged as ineligible by clinical investigators 8.Patients with type 1 diabetes
研究者
相似试验
已完成
不适用
Comparison of Insulin degludec vs. Insulin glargine using continuous glucose monitoring (CGM): Crossover studyJPRN-UMIN000010847Ichinomiyanishi Hospital16
已完成
不适用
Comparison of the efficacy of insulin degludec/insulin aspart and insulin degludec/liraglutide in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000039221Minami Osaka Hospital24
招募中
Unknown
Comparison of insulin degludec/liraglutide versus insulin degludec in multiple daily injection therapy on subjects with type 2 diabetes; time to reach target glycemic levelsType 2 diabetesJPRN-UMIN000052156Kushiro Red Cross Hospital30
进行中（未招募）
不适用
Impact of Insulin Glargine compared to Insulin Detemir in combination with Metformin (BOT) on prandial beta cell function and overall metabolic control in type 2 diabetic patients with insufficient metabolic control during OAD Treatment - Insulin glargine and prandial beta cell functionDiabetes mellitus Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006109-26-DEInstitut für Klinische Forschung und Entwicklung (ikfe) GmbH
招募中
不适用
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30